Navigation Links
Florida Woman Developed Bladder Cancer After Taking Actos to Treat her Type II Diabetes, Alleges Lawsuit Filed by Parker Waichman LLP
Date:8/14/2013

(PRWEB) August 15, 2013

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, has filed a lawsuit alleging that Actos caused a Florida woman to develop bladder cancer. The suit was filed on July 15, 2013, in the U.S. District Court for the Western District of Louisiana (Case No. 6:13-cv-2244). It is one of thousands of cases filed as part of the multidistrict litigation (MDL) entitled In Re: Actos (pioglitazone) Products Liability Litigation (6:11-md-2299). Takeda Pharmaceuticals, America; Takeda Pharmaceuticals USA, Inc. f/k/a Takeda Pharmaceuticals North America, Inc.; Takeda Pharmaceutical Company Limited; and Eli Lilly and Company have been named as Defendants. Jerrold S. Parker, founding partner of Parker Waichman LLP, serves on the Plaintiffs’ Steering Committee in the litigation.

According to the Complaint, the Plaintiff started taking Actos from about June 2006 to January 2010, which is when she started to suffer from bladder cancer, allegedly due to Actos. The U.S. Food and Drug Administration (FDA) has warned about the risks of taking Actos. On June 15, 2011, the agency said that taking Actos for more than a year could significantly increase the risk of bladder cancer. The safety label on Actos was updated to address this risk.

Some research studies provide additional support for the notion of a link between Actos and bladder cancer. The British Medical Journal published a study on May 31, 2012, that revealed Actos users were twice as likely to develop bladder cancer after two years. Then, on July 3, 2012, the Canadian Medical Association Journal reported that patients taking the medication were 22 percent more likely to get bladder cancer.

Parker Waichman LLP continues to offer free legal consultations to victims of injuries allegedly caused by Actos, including bladder cancer, heart problems, and eye injuries. If you or a loved one were diagnosed with bladder cancer after taking Actos, please contact their office by visiting yourlawyer.com. Free case evaluations are also available by calling 1-800-LAW-INFO (1-800-529-4636).

Contact:
Parker Waichman LLP
Gary Falkowitz, Managing Attorney
(800) LAW-INFO
(800) 529-4636
http://www.yourlawyer.com

Read the full story at http://www.prweb.com/releases/actos_lawsuit_terilla/08/prweb11028731.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Chinese Drywall Complaint Center Now Demands Leadership From Obama & EPA, For Homeowners In Florida And In The US Southeast Stuck In Toxic Chinese Drywall Hell-Forward?
2. Scripps Florida scientists awarded nearly $1.5 million to develop new approaches to treat cancer
3. Cleveland Clinic Florida receives approval for transplant programs at Weston Facilities
4. Scripps Florida scientists uncover a novel cooperative effort to stop cancer spread
5. Florida Dentistry Office Whitens Teeth for Charity
6. Scripps Florida scientist awarded $2.5 million to study inner workings of memory formation
7. Nuvia Cafe to be Showcased at the Soho Expo in Orlando, Florida: December 8-9, 2012.
8. PVI Solar Installs The Largest Solar Powered Sign In The U.S. For A St. Petersburg, Florida Based Software Firm, Clairfire
9. Scripps Florida scientists develop new compound that reverses fatty liver disease
10. Scripps Florida scientists create new approach to destroy disease-associated RNAs in cells
11. Hearing and Balance Associates of NW Florida Releases New Website for Hearing Aids in Tallahassee FL
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... typically been previously exposed to more adverse experiences than children in the general ... trauma such as abuse, neglect or other family challenges. While no fault of ...
(Date:4/28/2017)... Harbor, Md. (PRWEB) , ... April 28, 2017 ... ... Care Association of America (UCAOA) and College of Urgent Care Medicine will host ... 2017 workshops, sessions and speakers will help those in the industry adapt to ...
(Date:4/28/2017)... ... April 28, 2017 , ... People are starting to accept that hearing ... aid doesn’t have the stigma it had when great-grandpa wore his hearing aids years ... in a NALA North American Speaker Series (NASS) segment. “He probably wore ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... which name the Creator responds to and which He does not. Yisrayl says with ... which one is the true name, but he says with a little Scripture, backed with ...
(Date:4/28/2017)... ... April 28, 2017 , ... Phytomer USA is pleased to ... 20+ years of experience within the beauty industry, ranging from marketing, retail support, ... high-end cosmetic brands, retail brands and outlets in Canada and New York. As ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  Cogentix Medical, Inc. ... on providing the Urology, Uro/Gyn and Gynecology markets ... Ash Keswani has joined the Company as Senior ... newly created position, Mr. Keswani will report directly ... "Our organization is delighted that Ash ...
(Date:4/20/2017)... , April 20, 2017 Research and ... Technologies - Innovation Driven by Rapidly Expanding Injectables Market and Increasing ... their offering. ... for drug delivery technologies will rise from USD 20 Billion in ... Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding ...
(Date:4/20/2017)... -- Eyevensys, a private biotechnology company developing ... technology that enables the safe, local, sustained production of ... range of ophthalmic diseases, announces it has received approval ... (MHRA) to advance its technology into clinical development. ... The EyeCET platform ...
Breaking Medicine Technology: